Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | David C. Smith, Lee S. Rosen, Rashmi Chugh, Jonathan Wade Goldman, Lu Xu, Ann Kapoun, Ranier K Brachmann, Jakob Dupont, Robert J. Stagg, Anthony W. Tolcher, Kyriakos P. Papadopoulos | ||||||||||||
Title | Phase 1b study of WNT inhibitor vantictumab (VAN, human monoclonal antibody) with Paclitaxel (P) in patients (pts) with 1st- to 3rd-line metastatic HER2-negative breast cancer (BC). | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/166396-176 | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 2516) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|